ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli

Kamal Veisi, Safar Farajnia*, Nosratollah Zarghami, Hamid Reza Khoram Khorshid, Nasser Samadi, Shiva Ahdi Khosroshahi, Hossein Zarei Jaliani

Adv Pharm Bull. 2015;5(5): 621-627. doi: 10.15171/apb.2015.084

PMCID: PMC4708032 PMID: 26793607 Scopus ID: 84954104894

Article

PDF

XML

Cited By:

Research Article

2. Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology

Leila Rahbarnia, Safar Farajnia*, Hossein Babaei, Jafar Majidi, Bahman Akbari, Shiva Ahdi khosroshahi

Adv Pharm Bull. 2016;6(4): 563-571. doi: 10.15171/apb.2016.070

PMCID: PMC5241414 PMID: 28101463 Scopus ID: 85011409896

Article

PDF

XML

Cited By:

Research Article

3. An Alignment-Independent 3D-QSAR Study of FGFR2 Tyrosine Kinase Inhibitors

Behzad Jafari, Maryam Hamzeh-Mivehroud, Ali Akbar Alizadeh, Mehdi Sharifi, Siavoush Dastmalchi*

Adv Pharm Bull. 2017;7(3): 409-418. doi: 10.15171/apb.2017.049

PMCID: PMC5651062 PMID: 29071223 Scopus ID: 85030089731

Article

PDF

XML

Cited By:

Research Article

4. Purification of a Novel Anti-VEGFR2 Single Chain Antibody Fragmentand Evaluation of Binding Affinity by Surface Plasmon Resonance

Shirafkan Kordi , Mohammad Rahmati-Yamchi , Mehdi Asghari Vostakolaei, Abolfazl Barzegari , Jalal Abdolalizadeh*

Adv Pharm Bull. 2019;9(1): 64-69. doi: 10.15171/apb.2019.008

PMCID: PMC6468230 PMID: 31011559 Scopus ID: 85064831417

Article

PDF

XML

Cited By:

Research Article

5. Expression of Diverse Angiogenesis Factor in Different Stages of the 4T1 Tumor as a Mouse Model of Triple-Negative Breast Cancer

Saba Malekian , Marveh Rahmati , Soyar Sari , Monireh Kazemimanesh , Raheleh Kheirbakhsh , Ahad Muhammadnejad , Saeid Amanpour*

Adv Pharm Bull. 2020;10(2): 323-328. doi: 10.34172/apb.2020.039

PMCID: PMC7191227 PMID: 32373503 Scopus ID: 85088709108

Article

PDF

Full Text

XML

Cited By:

Research Article

6. miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1

Solmaz Shirjang , Behzad Mansoori, Ali Mohammadi, Neda Shajari, Pascal H.G. Duijf, Souzan Najafi, Fereydoon Abedi Gaballu, Katayoon Nofouzi, Behzad Baradaran*

Adv Pharm Bull. 2020;10(3): 444-451. doi: 10.34172/apb.2020.054

PMCID: PMC7335988 PMID: 32665904 Scopus ID: 85088614001

Article

PDF

Full Text

XML

Cited By:

Review Article

7. Challenges of Serum Creatinine Level in GFR Assessment and Drug Dosing Decisions in Kidney Injury

Xinyi Wang , Jing Mu, Kexin Ma, Yanrong Ma*

Adv Pharm Bull. 2024;14(4): 745-758. doi: 10.34172/apb.42345

Article

PDF

Suppl 1

XML

Cited By: